NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
5.16
+0.32 (6.61%)
At close: Aug 1, 2025, 4:00 PM
5.06
-0.10 (-1.94%)
After-hours: Aug 1, 2025, 7:31 PM EDT

H&E Equipment Services Statistics

Total Valuation

NeoGenomics has a market cap or net worth of $666.56 million. The enterprise value is $914.64 million.

Market Cap666.56M
Enterprise Value 914.64M

Important Dates

The last earnings date was Tuesday, July 29, 2025, before market open.

Earnings Date Jul 29, 2025
Ex-Dividend Date n/a

Share Statistics

NeoGenomics has 129.18 million shares outstanding. The number of shares has increased by 1.05% in one year.

Current Share Class 129.18M
Shares Outstanding 129.18M
Shares Change (YoY) +1.05%
Shares Change (QoQ) +0.45%
Owned by Insiders (%) 1.22%
Owned by Institutions (%) 95.57%
Float 127.06M

Valuation Ratios

PE Ratio n/a
Forward PE 35.37
PS Ratio 0.95
Forward PS 0.84
PB Ratio 0.78
P/TBV Ratio 23.72
P/FCF Ratio n/a
P/OCF Ratio 47.45
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.33
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.92, with a Debt / Equity ratio of 0.48.

Current Ratio 3.92
Quick Ratio 3.16
Debt / Equity 0.48
Debt / EBITDA 97.85
Debt / FCF n/a
Interest Coverage -13.50

Financial Efficiency

Return on equity (ROE) is -11.76% and return on invested capital (ROIC) is -3.52%.

Return on Equity (ROE) -11.76%
Return on Assets (ROA) -3.23%
Return on Invested Capital (ROIC) -3.52%
Return on Capital Employed (ROCE) -6.07%
Revenue Per Employee $313,268
Profits Per Employee -$47,290
Employee Count2,200
Asset Turnover 0.45
Inventory Turnover 13.47

Taxes

Income Tax -1.41M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -70.90% in the last 52 weeks. The beta is 1.62, so NeoGenomics's price volatility has been higher than the market average.

Beta (5Y) 1.62
52-Week Price Change -70.90%
50-Day Moving Average 6.99
200-Day Moving Average 11.36
Relative Strength Index (RSI) 29.52
Average Volume (20 Days) 2,746,713

Short Selling Information

Short Interest 4.27M
Short Previous Month 4.54M
Short % of Shares Out 3.31%
Short % of Float 3.36%
Short Ratio (days to cover) 2.18

Income Statement

In the last 12 months, NeoGenomics had revenue of $689.19 million and -$104.04 million in losses. Loss per share was -$0.82.

Revenue689.19M
Gross Profit 302.64M
Operating Income -78.54M
Pretax Income -83.44M
Net Income -104.04M
EBITDA -7.38M
EBIT -78.54M
Loss Per Share -$0.82
Full Income Statement

Balance Sheet

The company has $163.69 million in cash and $411.76 million in debt, giving a net cash position of -$248.08 million or -$1.92 per share.

Cash & Cash Equivalents 163.69M
Total Debt 411.76M
Net Cash -248.08M
Net Cash Per Share -$1.92
Equity (Book Value) 854.04M
Book Value Per Share 6.67
Working Capital 292.43M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $14.05 million and capital expenditures -$33.22 million, giving a free cash flow of -$19.17 million.

Operating Cash Flow 14.05M
Capital Expenditures -33.22M
Free Cash Flow -19.17M
FCF Per Share -$0.15
Full Cash Flow Statement

Margins

Gross margin is 43.91%, with operating and profit margins of -11.40% and -15.10%.

Gross Margin 43.91%
Operating Margin -11.40%
Pretax Margin -15.30%
Profit Margin -15.10%
EBITDA Margin -1.07%
EBIT Margin -11.40%
FCF Margin n/a

Dividends & Yields

NeoGenomics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.05%
Shareholder Yield -1.05%
Earnings Yield -15.61%
FCF Yield -2.88%
Dividend Details

Analyst Forecast

The average price target for NeoGenomics is $12.14, which is 135.27% higher than the current price. The consensus rating is "Buy".

Price Target $12.14
Price Target Difference 135.27%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (5Y) 11.88%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on April 16, 2003. It was a reverse split with a ratio of 1:100.

Last Split Date Apr 16, 2003
Split Type Reverse
Split Ratio 1:100

Scores

Altman Z-Score n/a
Piotroski F-Score 5